nad has been researched along with Skin Neoplasms in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (18.52) | 18.7374 |
1990's | 5 (18.52) | 18.2507 |
2000's | 5 (18.52) | 29.6817 |
2010's | 9 (33.33) | 24.3611 |
2020's | 3 (11.11) | 2.80 |
Authors | Studies |
---|---|
Audrito, V; Calautti, E; Fiorilla, I; Indini, A; Ponzone, L | 1 |
Abeni, D; Campione, E; Candi, E; Dellambra, E; Fania, L; Mazzanti, C | 1 |
Cherepanoff, S; Conway, RM; Gratton, E; Macmillan, A; Madigan, MC; Sitiwin, E; Whan, R | 1 |
Cai, Y; Li, X | 1 |
Fink, C; Haenssle, H; Scharlach, C; Szyc, Ł | 1 |
Ballotti, R; Bertolotto, C; Ohanna, M | 1 |
Ballotti, R; Bertolotto, C; Healy, E | 1 |
Derjabo, A; Ferulova, I; Lange, M; Lihachev, A; Lihacova, I; Spigulis, J | 1 |
Fu, J; Li, Q; Liu, Y; Min, W; Song, N; Wang, H; Yu, Y; Yuan, K; Zhang, X; Zhang, Y; Zheng, X; Zhou, N | 1 |
Bonder, CS; Pastore, MN; Roberts, MS; Studier, H | 1 |
Benavente, CA; Jacobson, EL; Jacobson, MK | 1 |
Bailey, N; Graber, D; Kudugunti, SK; Moridani, MY; Srivenugopal, K; Vad, NM | 1 |
Adam, J; Chaneton, B; Deberardinis, RJ; Folger, O; Frezza, C; Gottlieb, E; Hedley, A; Jerby, L; Kalna, G; MacKenzie, ED; Micaroni, M; Pollard, PJ; Rajagopalan, KN; Ruppin, E; Shlomi, T; Tomlinson, IP; Watson, DG; Zheng, L | 1 |
Ding, Y; Jin, D; Li, Z; Peng, T; Ren, Q; Tang, Y; Wang, W; Xi, P; Xie, H | 1 |
AUERBACH, WM | 1 |
BRAUN-FALCO, O; PETZOLDT, D | 1 |
Kirkland, JB | 1 |
Barrios, R; Brayton, C; Gaikwad, A; Iskander, K; Jaiswal, AK; Long, DJ; Paquet, M | 1 |
Benavente, CA; Jacobson, EL | 1 |
Huang, AC; Jacobson, EL; Shieh, WM | 1 |
Gensler, HL; Huang, AC; Jacobson, EL; Williams, T | 1 |
Hoogduijn, MJ; Pavel, S; Riley, PA; Smit, NP | 1 |
Alfano, RR; Papadopoulos, AJ; Steinberg, ML; Zhadin, NN | 1 |
De Bersaques, J | 1 |
Gebhart, W; Knobler, RM; Neumann, RA; Pieczkowski, F | 1 |
Castro, C; Winkelmann, RK | 1 |
Alcini, E; Cappelletti, F; Di Curzio, B | 1 |
4 review(s) available for nad and Skin Neoplasms
Article | Year |
---|---|
NAD/NAMPT and mTOR Pathways in Melanoma: Drivers of Drug Resistance and Prospective Therapeutic Targets.
Topics: Cytokines; Drug Resistance; Humans; Melanoma; NAD; Nicotinamide Phosphoribosyltransferase; Protein Kinase Inhibitors; Skin Neoplasms; TOR Serine-Threonine Kinases; Tumor Microenvironment | 2022 |
Role of Nicotinamide in Genomic Stability and Skin Cancer Chemoprevention.
Topics: Animals; Energy Metabolism; Genomic Instability; Humans; Immunosuppression Therapy; NAD; Niacinamide; Skin Aging; Skin Neoplasms; Ultraviolet Rays | 2019 |
NAD in skin: therapeutic approaches for niacin.
Topics: Antineoplastic Agents; Humans; NAD; Niacin; Skin; Skin Neoplasms | 2009 |
Niacin and carcinogenesis.
Topics: Adenosine Diphosphate Ribose; Animals; Apoptosis; DNA Repair; Humans; NAD; Neoplasms; Niacin; Nutritional Status; Poly(ADP-ribose) Polymerases; Skin Neoplasms; Tumor Suppressor Protein p53 | 2003 |
23 other study(ies) available for nad and Skin Neoplasms
Article | Year |
---|---|
Shedding light on melanins within in situ human eye melanocytes using 2-photon microscopy profiling techniques.
Topics: Aged; Choroid; Cytoplasm; Female; Fundus Oculi; HEK293 Cells; Humans; Male; Melanins; Melanocytes; Melanoma; Melanosomes; Microscopy; Middle Aged; NAD; Photons; Pigmentation; Skin Neoplasms | 2019 |
Risk stratification of cutaneous melanoma reveals carcinogen metabolism enrichment and immune inhibition in high-risk patients.
Topics: Biomarkers, Tumor; Clinical Decision-Making; Databases, Genetic; Decision Support Techniques; Disease Progression; Female; Gene Expression Profiling; Gene Regulatory Networks; GTP Phosphohydrolases; Humans; Intraepithelial Lymphocytes; Lymphocytes, Tumor-Infiltrating; Male; Melanoma; Membrane Proteins; Middle Aged; NAD; Neurofibromin 1; Predictive Value of Tests; Prognosis; Proto-Oncogene Proteins B-raf; Reproducibility of Results; Risk Assessment; Risk Factors; RNA-Seq; Skin Neoplasms; T-Lymphocytes, Regulatory; Transcriptome; Tumor Microenvironment | 2020 |
In vivo two-photon-excited cellular fluorescence of melanin, NAD(P)H, and keratin enables an accurate differential diagnosis of seborrheic keratosis and pigmented cutaneous melanoma.
Topics: Adult; Diagnosis, Differential; Humans; Keratins; Keratosis, Seborrheic; Melanins; Melanoma; NAD; Skin Neoplasms | 2021 |
[Key role of nicotinamide phosphoribosyltransferase (NAMPT) and NAD metabolism in the transition of melanoma cells to an invasive and drug-resistant phenotype].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cytokines; Drug Resistance, Neoplasm; Enzyme Inhibitors; Humans; Melanoma; Molecular Targeted Therapy; NAD; Neoplasm Invasiveness; Nicotinamide Phosphoribosyltransferase; Phenotype; Skin Neoplasms | 2018 |
Nicotinamide as a chemopreventive therapy of skin cancers. Too much of good thing?
Topics: Chemoprevention; Humans; NAD; Niacinamide; Signal Transduction; Skin Neoplasms | 2019 |
Autofluorescence imaging of basal cell carcinoma by smartphone RGB camera.
Topics: Carcinoma, Basal Cell; Collagen; Dermoscopy; Fluorescence; Humans; Light; Microscopy, Fluorescence; NAD; Nevus; Photobleaching; Porphyrins; Skin; Skin Neoplasms; Smartphone | 2015 |
Gene silencing of indoleamine 2,3-dioxygenase 2 in melanoma cells induces apoptosis through the suppression of NAD+ and inhibits in vivo tumor growth.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Indoleamine-Pyrrole 2,3,-Dioxygenase; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; NAD; Neoplasm Invasiveness; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; RNAi Therapeutics; Signal Transduction; Skin Neoplasms; Time Factors; Transfection; Tumor Burden | 2016 |
Non-invasive metabolic imaging of melanoma progression.
Topics: Animals; Cell Line, Tumor; Disease Progression; Epidermis; Female; Keratinocytes; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence, Multiphoton; NAD; Neoplasm Staging; Skin Neoplasms | 2017 |
Efficacy of acetaminophen in skin B16-F0 melanoma tumor-bearing C57BL/6 mice.
Topics: Acetaminophen; Animals; Antineoplastic Agents; Ascorbic Acid; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Glutathione; Humans; Inhibitory Concentration 50; Kidney; Lipid Peroxidation; Liver; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Monophenol Monooxygenase; NAD; Oxidation-Reduction; Phenacetin; Reactive Oxygen Species; RNA Interference; Skin Neoplasms; Sulfhydryl Compounds; Time Factors | 2009 |
Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase.
Topics: Animals; Bilirubin; Cell Line; Cells, Cultured; Citric Acid Cycle; Computer Simulation; Fumarate Hydratase; Fumarates; Genes, Lethal; Genes, Tumor Suppressor; Glutamine; Heme; Heme Oxygenase (Decyclizing); Kidney Neoplasms; Leiomyomatosis; Mice; Mitochondria; Mutation; NAD; Neoplastic Syndromes, Hereditary; Skin Neoplasms; Uterine Neoplasms | 2011 |
CRAFT: Multimodality confocal skin imaging for early cancer diagnosis.
Topics: Animals; Early Detection of Cancer; Female; Flavin-Adenine Dinucleotide; Mice; NAD; NADP; Skin; Skin Neoplasms; Spectrometry, Fluorescence; Tomography | 2012 |
HISTOCHEMISTRY OF HYDROLYTIC AND OXIDATIVE ENZYMES IN EXPERIMENTAL SKIN CARCINOMA OF THE MOUSE.
Topics: Acid Phosphatase; Adenosine Triphosphatases; Animals; Benz(a)Anthracenes; Carcinoma, Squamous Cell; Dihydrolipoamide Dehydrogenase; Histocytochemistry; Mice; Mitochondria; NAD; NADP; Neoplasms, Experimental; Pathology; Research; Skin Neoplasms | 1964 |
[ON THE HISTOTOPIC PICTURE OF NADH- AND NADPH-TETRAZOLIUM REDUCTASE IN HUMAN SKIN. II. PATHOLOGICALLY CHANGED SKIN AND TUMORS].
Topics: Histocytochemistry; Humans; NAD; NADPH-Ferrihemoprotein Reductase; Oxidoreductases; Skin Diseases; Skin Neoplasms; Tetrazolium Salts | 1965 |
Lower induction of p53 and decreased apoptosis in NQO1-null mice lead to increased sensitivity to chemical-induced skin carcinogenesis.
Topics: 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; Animals; Apoptosis; Benzo(a)pyrene; Carcinogens; Female; Inactivation, Metabolic; Male; Mice; Mice, Inbred C57BL; NAD; NAD(P)H Dehydrogenase (Quinone); NADPH Dehydrogenase; Oxidation-Reduction; Skin; Skin Neoplasms; Tetradecanoylphorbol Acetate; Tumor Suppressor Protein p53 | 2005 |
Niacin restriction upregulates NADPH oxidase and reactive oxygen species (ROS) in human keratinocytes.
Topics: Cell Cycle; Cell Proliferation; Cells, Cultured; DNA Damage; Glutaminase; Humans; Keratinocytes; NAD; NADPH Oxidases; Niacin; Oxidation-Reduction; Reactive Oxygen Species; Signal Transduction; Skin Neoplasms; Up-Regulation | 2008 |
Mapping the role of NAD metabolism in prevention and treatment of carcinogenesis.
Topics: Animals; Breast Neoplasms; Humans; Lung Neoplasms; NAD; Neoplasms; Niacin; Rats; Skin; Skin Neoplasms; Species Specificity; Time Factors; Tissue Distribution; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1999 |
Oral niacin prevents photocarcinogenesis and photoimmunosuppression in mice.
Topics: Administration, Oral; Animals; Anticarcinogenic Agents; Antigens, Neoplasm; Dietary Supplements; Dose-Response Relationship, Drug; Female; Immunization, Passive; Immunosuppression Therapy; Mice; Mice, Inbred BALB C; NAD; Neoplasms, Radiation-Induced; Niacin; Skin; Skin Neoplasms; Specific Pathogen-Free Organisms; Ultraviolet Rays | 1999 |
Study of DT-diaphorase in pigment-producing cells.
Topics: Anisoles; Catechol O-Methyltransferase; Catechol O-Methyltransferase Inhibitors; Cells, Cultured; Colorimetry; Enzyme Induction; Epidermal Cells; Epidermis; Flavin-Adenine Dinucleotide; Humans; Hydrogen; Melanins; Melanocytes; Melanoma; NAD; NAD(P)H Dehydrogenase (Quinone); NADP; Neoplasm Proteins; Skin Neoplasms; Skin Pigmentation; Spectrophotometry; Tumor Cells, Cultured | 1999 |
Fluorescence spectroscopy of normal, SV40-transformed human keratinocytes, and carcinoma cells.
Topics: Carcinoma, Squamous Cell; Cell Line, Transformed; Cell Transformation, Viral; Cells, Cultured; Epidermal Cells; Humans; Keratinocytes; Mitochondria; NAD; Simian virus 40; Skin Neoplasms; Spectrometry, Fluorescence; Tumor Cells, Cultured | 1999 |
Glutathione reductase in human epidermal tumors. Basal and squamous cell epithelioma, verruca seborrhoeica.
Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Epidermis; Glutathione Reductase; Humans; Keratosis; NAD; NADP; Skin Neoplasms; Warts | 1979 |
Enzyme histochemical analysis of cell viability after argon laser-induced coagulation necrosis of the skin.
Topics: Adult; Argon; Cell Survival; Cytoplasm; Cytoplasmic Granules; Dihydrolipoamide Dehydrogenase; Epidermis; Hemangioma; Histocytochemistry; Humans; Lasers; Light Coagulation; Middle Aged; NAD; NADP; Necrosis; Nitroblue Tetrazolium; Oxidation-Reduction; Skin; Skin Neoplasms; Time Factors | 1991 |
Angiolymphoid hyperplasia with eosinophilia in the skin.
Topics: Adenosine Triphosphatases; Alkaline Phosphatase; Cytoplasm; Eosinophilia; Hemangiosarcoma; Histiocytes; Histocytochemistry; Hyperplasia; Inflammation; Microscopy, Electron; NAD; Skin; Skin Neoplasms | 1974 |
[Metabolic aspects of keratoacanthoma in relation to its etiologic significance].
Topics: Diagnosis, Differential; Glucosephosphate Dehydrogenase; Histocytochemistry; Humans; Isocitrate Dehydrogenase; Keratoacanthoma; L-Lactate Dehydrogenase; Malate Dehydrogenase; NAD; NADP; Skin Neoplasms; Succinate Dehydrogenase | 1969 |